BICILLIN C-R 900/300 (penicillin g benzathine)
BICILLIN C-R 900/300 is indicated for the treatment of Upper Respiratory Tract Infection; Scarlet Fever; Erysipelas; Skin and Soft Tissue Infection; Pneumonia; Otitis Media.
How BICILLIN C-R 900/300 Works
Penicillin G exerts bactericidal action against susceptible microorganisms during the stage of active multiplication. It acts by inhibiting the biosynthesis of cell-wall peptidoglycan, rendering the bacterial cell wall osmotically unstable, which results in bacterial cell death.
Details
- Status
- Prescription
- First Approved
- 1953-05-18
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
Companies
BICILLIN C-R 900/300 Approval History
What BICILLIN C-R 900/300 Treats
6 indicationsBICILLIN C-R 900/300 is approved for 6 conditions since its original approval in 1953. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Upper Respiratory Tract Infection
- Scarlet Fever
- Erysipelas
- Skin and Soft Tissue Infection
- Pneumonia
- Otitis Media
BICILLIN C-R 900/300 Boxed Warning
NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling....
WARNING: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling.
BICILLIN C-R 900/300 Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to BICILLIN C-R 900/300
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03612557 | B8441001 | Ph 1 | completed | A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BICILLIN C-R 900/300 FDA Label Details
Indications & Usage
FDA Label (PDF)BICILLIN C-R 900/300 is indicated for the treatment of Upper Respiratory Tract Infection; Scarlet Fever; Erysipelas; Skin and Soft Tissue Infection; Pneumonia; Otitis Media.
WARNING: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this dru...
Track BICILLIN C-R 900/300 with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.